SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-23-117321
Filing Date
2023-11-13
Accepted
2023-11-13 17:08:06
Documents
3
Group Members
AARON GLEN LOUIS FLETCHERBIOS ADVISORS GP, LLCBIOS CAPITAL MANAGEMENT, LPBIOS CLINICAL OPPORTUNITY FUND, LPBIOS EQUITY COF, LPBIOS EQUITY PARTNERS II, LPBIOS EQUITY PARTNERS III, LPBIOS EQUITY PARTNERS, LPBIOS FUND I QP, LPBIOS FUND II NT, LPBIOS FUND II

Document Format Files

Seq Description Document Type Size
1 SC 13G tm2330603d2_sc13g.htm SC 13G 435973
2 EXHIBIT 99.1 tm2330603d2_ex99-1.htm EX-99.1 97671
3 EXHIBIT 99.2 tm2330603d2_ex99-2.htm EX-99.2 97910
  Complete submission text file 0001104659-23-117321.txt   633873
Mailing Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451
Business Address 738 MAIN STREET UNIT 398 WALTHAM MA 02451 617-995-0900
AILERON THERAPEUTICS INC (Subject) CIK: 0001420565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90032 | Film No.: 231399957
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107
Business Address 1401 FOCH STREET SUITE 140 FORT WORTH TX 76107 817-984-5964
BIOS Fund I, LP (Filed by) CIK: 0001697316 (see all company filings)

IRS No.: 815006136 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G